Ms. Rachel Trevino Ortiz, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 496-371-866109 Fax: 496-371-866109 |
Lauren Kelly Panneck, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Tower Barracks Family Advocacy Program, Building 158, Apo, AE 09114 Phone: 314-590-3103 |
Jessie Kehaulani Higa Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-545-1337 |
Mrs. Marion Garza, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-4304 |
Mr. Nicolas Araiza Jr., LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: Unit 5115 Box 48th, Apo, AE 09461 Phone: 314-226-8603 |
Mr. John Calvin Hartz, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Schweinfurt Army Health Clinic, Cmr 457, Unit 25850, Box 718, Apo, AE 09033 Phone: 011-499-72196 Fax: 011-499-721966872 |
Jesse Gilley Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 851 Box 340, Fpo, AE 09834 Phone: 318-439-4260 |
Ms. Jeanie Heugo, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Psc 808, Fpo, AE 09618 Phone: 011-081-6372 Fax: 011-081-6562 |
Mr. Eric Henderson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Navy Branch Health Clinic, Psc 851 Box 340, Fpo, AE 09834 Phone: 318-439-4169 |
Ms. Marlo Marie Narro, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Usnh-gtmo, Box 115, Fpo, AE 09589 Phone: 810-210-0347 |
News Archive
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers. Survival was shown to be greatest among those prescribed first-generation nonselective beta-blockers.
Hemispherx Biopharma, Inc. announced that the Company has entered into an agreement with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA for the marketing of Alferon N Injection®, the Company's natural interferon injection product which has been FDA approved for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries upon receipt of those respective countries' regulatory approval for any use of the product.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
GlaxoSmithKline (GSK) has announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC) and ovarian cancer.
Leaders from healthcare, technology companies and academia will meet on Tuesday, Aug. 24, for a day-long session in the Chippewa Valley technology corridor. Participants will discuss how the use of technology and innovation can help overcome some of the biggest challenges facing the healthcare industry.
› Verified 2 days ago